Mononucleosis risk factors: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 44: Line 44:
[[Category:Medicine]]
[[Category:Medicine]]
[[Category:Otolaryngology]]
[[Category:Otolaryngology]]
[[Category:Mature chapter]]
 
[[Category:Lymphocytes]]
[[Category:Lymphocytes]]
[[Category:Viral diseases]]
[[Category:Viral diseases]]

Revision as of 17:32, 19 December 2012

Mononucleosis Microchapters

Home

Patient Information

Overview

Pathophysiology

Epidemiology and Demographics

Risk Factors

Causes

Differentiating Mononucleosis from other Diseases

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Mononucleosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Mononucleosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Mononucleosis risk factors

CDC on Mononucleosis risk factors

Mononucleosis risk factors in the news

Blogs on Mononucleosis risk factors

Directions to Hospitals Treating Mononucleosis

Risk calculators and risk factors for Mononucleosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [2]

Overview

Majority of the population become infected with EBV at sometime during their lives with an estimated 90%-95% of adults demonstrating seropositivity by 21 years of age. Therefore, even individuals exposed to infected contacts have shown to be previously infected with EBV and hence are not at risk for the manifestation of mononucleosis. However, once infected, the patient carries the virus for the rest of their life with the virus typically residing dormantly in the B lymphocytes. Independent infections of mononucleosis may be contracted multiple times, regardless of whether the patient is already carrying the virus dormantly. Periodic reactivation of the virus may occur, during which time the patient is again infectious, but usually without any symptoms of illness. Therefore, in susceptible hosts under the appropriate environmental stressors, reactivation of the virus occurs to cause vague subclinical symptoms or remain mostly asymptomatic and diagnosed only by a positive serologic response. However, its imperative to note that during this phase the virus can spread to others.

High-Risk Population

By Epidemiology

  • It is predominantly found in under-developed countries, and almost everyone is exposed to the ebstein barr virus by 18 months of age. Therefore, even individuals exposed to infected contacts are not at risk for the manifestation of the disease. Additionally, antibody to the virus is almost universally positive.
  • In the United States, roughly half of five-year-olds have been infected [1] and up to 95% of adults between 35 and 40 years of age.[2]

By Age

  • Children if infected with EBV usually remain asymptomatic and hence are indistinguishable from the other mild, brief illnesses of childhood. However, when the infection occurs during adolescence or young adulthood, it causes acute infectious mononucleosis 35% to 50% of the time.
  • Among adults, increased risk of acquiring mononucleosis is observed among:
  • adolescents and young adults
  • patients who have intimate contact with the saliva of an infected person
  • contact with the airborne virus

By Immune System Status

  • Any condition that weakens the immune system is a predisposing factor for the development of mononucleosis secondary to EBV infection. Such states include:

By Genetic Susceptibility

  • A recent twin study done to assess the genetic susceptibility to infectious mononucleosis demonstrated results compatible with a heritable contribution to the risk of acquiring mononucleosis.[3]

References

  1. [1]
  2. Epstein-Barr Virus and Infectious Mononucleosis - National Center for Infectious Diseases
  3. Hwang AE, Hamilton AS, Cockburn MG, Ambinder R, Zadnick J, Brown EE, Mack TM, Cozen W (2011). "Evidence of genetic susceptibility to infectious mononucleosis: a twin study". Epidemiology and Infection: 1–7. doi:10.1017/S0950268811002457. PMID 22152594. Retrieved 2012-02-29. Unknown parameter |month= ignored (help)


Template:WikiDoc Sources